Journal profile · Pharmacology, Toxicology and Pharmaceutics-Pharmacology
Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry
ISSN 1871-5230 · eISSN 1875-614X · Bentham
Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry: subscription journal; median 98 days to acceptance (48 articles, last 24 months); 18 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry is published by Bentham. By OpenAlex counts of its recent articles, its largest topics are Inflammatory mediators and NSAID effects, Synthesis and biological activity and Asthma and respiratory diseases, together about 27% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Pharmacology, Toxicology and Pharmaceutics-Pharmacology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Inflammatory mediators and NSAID effectsMedicine11.3%
- Synthesis and biological activityChemistry8%
- Asthma and respiratory diseasesMedicine7.7%
- Rheumatoid Arthritis Research and TherapiesMedicine5.3%
- Natural Compounds in Disease TreatmentMedicine5.3%
- Medicinal Plant ResearchAgricultural and Biological Sciences5.1%
- Allergic Rhinitis and SensitizationMedicine4.8%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pharmacology | Q3 | 201/328 | 38th |
| Immunology and Allergy | Q3 | 155/234 | 33rd |
| Immunology | Q3 | 165/243 | 32nd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 3.4LetPub ·
- SJR 2026-06
- 0.47LetPub ·
- SNIP 2026-06
- 0.64LetPub ·
- h-index
- 35OpenAlex ·
- i10-index
- 172OpenAlex ·
- 2-year mean citedness
- 2.32OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 795 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 36 | 0 | 456 |
| 2025 | 18 | 1 | 647 |
| 2024 | 31 | 2 | 670 |
| 2023 | 26 | 1 | 613 |
| 2022 | 0 | 0 | 621 |
| 2021 | 33 | 3 | 562 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
98 daysMedian, submission to acceptance · P25–P75 74 days – 118 days
- Acceptance to online
- median 229 days (48 articles)
- Submission to online
- median 317 days
- Sample
- 48 articles with submission and acceptance dates (67 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Bentham
- ISSN
- 1871-5230
- Electronic ISSN
- 1875-614X
FAQ
Frequently asked questions about Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry
How long does peer review take at Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry?
Based on the dates recorded on 48 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 98 days (interquartile range 74–118 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry?
According to LetPub and DOAJ records, Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry is indexed in Scopus.
Is Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry open access, and what is the APC?
Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .